Analysis of prolactin-modulated gene expression profiles during the Nb2 cell cycle using differential screening techniques

Genome Biology

Volumn 1, Issue 4, 2000, Pages

  Bole Feysot, Christine ^a   Perret, Eric ^b   Roustan, Paul ^b   Bouchard, Brigitte ^a   Kelly, Paul A ^a  

^a INSERM   (France)

^b SANOFI   (France)

Author keywords

Focal Adhesion Kinase; mRNA Differential Display; Prolactin; Representational Difference Analysis; Subtractive Suppressive Hybridization

Indexed keywords

MESSENGER RNA; PROLACTIN; RNA; TUMOR PROTEIN;

ANIMAL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CLASSIFICATION; DRUG EFFECT; EUKARYOTIC CELL; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MAMMAL; METABOLISM; METHODOLOGY; MOLECULAR CLONING; PATHOLOGY; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; CLONING, MOLECULAR; EUKARYOTIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMALS; NEOPLASM PROTEINS; PROLACTIN; RATS; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0034568794     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2000-1-4-research0008     Document Type: Article

References (84)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA: Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998, 19: 225-268. DOI: 10.1210/edrv.19.3.0334
2. Yu-Lee LY: Molecular actions of prolactin in the immune system. Proc Soc Exp Biol Med. 1997, 215: 35-52. DOI: 10.3181/00379727-215-44111
3. Clevenger CV, Freier DO, Kline JB: Prolactin receptor signal transduction in cells of the immune system. J Endocrinol. 1998, 157: 187-197. DOI: 10.1677/joe.0.1570187
4. Richards JF, Beer CT, Bourgeault C, Chen K, Gout PW: Biochemical response of lymphoma cells to mitogenic stimulation by prolactin. Mol Cell Endocrinol. 1982, 26: 41-49. 10.1016/0303-7207(82)90005-3. DOI: 10.1016/0303-7207(82)90005-3
5. Gertler A, Walker A, Friesen HG: Enhancement of human growth hormone-stimulated mitogenesis of Nb2 node lymphoma cells by 12-O-tetradecanoyl-phorbol-13-acetate. Endocrinology. 1985, 116: 1636-1644. DOI: 10.1210/endo-116-4-1636
6. Yu-Lee LY: Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells. Mol Cell Endocrinol. 1990, 68: 21-28. 10.1016/0303-7207(90)90165-5. DOI: 10.1016/0303-7207(90)90165-5
7. Stevens AM, Wang YF, Sieger KA, Lu HF, Yu-Lee LY: Biphasic transcriptional regulation of the interferon regulatory factor- 1 gene by prolactin: involvement of gamma-interferon-activated sequence and Stat-related proteins. Mol Endocrinol. 1995, 9: 513-525.
8. Hosokawa Y, Onga T, Nakashima K: Induction of D2 and D3 cyclin-encoding genes during promotion of the G1/S transition by prolactin in rat Nb2 cells. Gene. 1994, 147: 249-252. 10.1016/0378-1119(94)90075-2. DOI: 10.1016/0378-1119(94)90075-2
9. Buckley AR, Buckley DJ, Leff MA, Hoover DS, Magnuson NS: Rapid induction of pim-1 expression by prolactin and interleukin-2 in rat Nb2 lymphoma cells. Endocrinology. 1995, 136: 5252-5259.
10. Gilks CB, Porter SD, Barker C, Tsichlis PN, Gout PW: Prolactin (PRL)-dependent expression of a zinc finger protein-encoding gene, Gfi-1, in Nb2 lymphoma cells: constitutive expression in autonomous sublines. Endocrinology. 1995, 136: 1805-1808.
11. Morris SM, Yu-Lee LY: Expression of RNUDC, a potential nuclear movement protein, in mammalian cells: localization to the Golgi apparatus. Exp Cell Res. 1998, 238: 23-32. 10.1006/excr.1997.3822. DOI: 10.1006/excr.1997.3822
12. Liang P, Pardee AB: Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science. 1992, 257: 967-971. DOI: 10.1126/science.1354393
13. Hubank M, Schatz DG: Identifying differences in mRNA expression by representational difference analysis of cDNA. Nucleic Acids Res. 1994, 22: 5640-5648. DOI: 10.1093/nar/22.25.5640
14. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA. 1996, 93: 6025-6030. 10.1073/pnas.93.12.6025. DOI: 10.1073/pnas.93.12.6025
15. Perret E, Ferran EA, Marinx O, Liauzun P, Dumont X, Fournier J, Kaghad M, Ferrara P, Caput D: Improved differential screening approach to analyse transcriptional variations in organized cDNA libraries. Gene. 1998, 208: 103-115. 10.1016/S0378-1119(97)00658-6. DOI: 10.1016/S0378-1119(97)00658-6
16. O'Neal KD, Schwarz LA, Yu-Lee LY: Prolactin receptor gene expression in lymphoid cells. Mol Cell Endocrinol. 1991, 82: 127-135. 10.1016/0303-7207(91)90023-L. DOI: 10.1016/0303-7207(91)90023-L
17. Hosokawa Y, Yang M, Kaneko S, Tanaka M, Nakashima K: Prolactin induces switching of T-cell receptor gene expression from alpha to gamma in rat Nb2 pre-T lymphoma cells (1). Biochem Biophys Res Commun. 1996, 220: 958-962. 10.1006/bbrc.1996.0514. DOI: 10.1006/bbrc.1996.0514
18. Andrews GK, Varma S, Ebner KE: Regulation of expression of c-fos and c-myc in rat lymphoma Nb-2 cells. Biochim Biophys Acta. 1987, 909: 231-236. 10.1016/0167-4781(87)90082-0. DOI: 10.1016/0167-4781(87)90082-0
19. Clevenger CV, Thickman K, Ngo W, Chang WP, Takayama S, Reed JC: Role of Bag-1 in the survival and proliferation of the cytokine-dependent lymphocyte lines, Ba/F3 and Nb2. Mol Endocrinol. 1997, 11: 608-618. DOI: 10.1210/mend.11.5.9925
20. Leff MA, Buckley DJ, Krumenacker JS, Reed JC, Miyashita T, Buckley AR: Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology. 1996, 137: 5456-5462.
21. Nemeth E, Bole-Feysot C, Tashima LS: Suppression subtractive hybridization (SSH) identifies prolactin stimulation of p38 MAP kinase gene expression in Nb2 T lymphoma cells: molecular cloning of rat p38 MAP kinase. J Mol Endocrinol. 1998, 20: 151-156. DOI: 10.1677/jme.0.0200151
22. Gollob JA, Schnipper CP, Murphy EA, Ritz J, Frank DA: The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of STAT serine phosphorylation. J Immunol. 1999, 162: 4472-4481.
23. De Maria R, Rippo MR, Schuchman EH, Testi R: Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med. 1998, 187: 897-902. 10.1084/jem.187.6.897. DOI: 10.1084/jem.187.6.897
24. Spellman PT, Sherlock G, Zhang MQ, Iyer VR, Anders K, Eisen MB, Brown PO, Botstein D, Futcher B: Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol Biol Cell. 1998, 9: 3273-3297. DOI: 10.1091/mbc.9.12.3273
25. Yeast Cell Cycle Analysis Project. [http://genome-www.stanford.edu/cellcycle]
26. Chu S, DeRisi J, Eisen M, Mulholland J, Botstein D, Brown PO, Herskowitz I: The transcriptional program of sporulation in budding yeast. Science. 1998, 282: 699-705. 10.1006/jmbi.1998.2134. DOI: 10.1126/science.282.5389.699
27. Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JF, Trent JM, Staudt LM, Hudson JJ, Boguski MS, et al: The transcriptional program in the response of human fibroblasts to serum. Science. 1999, 283: 83-87. 10.1126/science.283.5398.83. DOI: 10.1126/science.283.5398.83
28. The transcriptional program in the response of human fibroblasts to serum. [http://genome-www.stanford.edu/serum]
29. Oehlen LJ, McKinney JD, Cross FR: Ste12 and Mcm1 regulate cell cycle-dependent transcription of FAR1. Mol Cell Biol. 1996, 16: 2830-2837. DOI: 10.1128/MCB.16.6.2830
30. Oehlen B, Cross FR: Signal transduction in the budding yeast Saccharomyces cerevisiae. Curr Opin Cell Biol. 1994, 6: 836-841. 10.1016/0955-0674(94)90053-1. DOI: 10.1016/0955-0674(94)90053-1
31. Scully R, Chen J, Plug A, Xiao Y, Weaver D, Feunteun J, Ashley T, Livingston DM: Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997, 88: 265-275. DOI: 10.1016/S0092-8674(00)81847-4
32. Weinert T: Yeast checkpoint controls and relevance to cancer. Cancer Surv. 1997, 29: 109-132.
33. Verlhac MH, Kubiak JZ, Weber M, Geraud G, Colledge WH, Evans MJ, Maro B: Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse. Development. 1996, 122: 815-822.
34. Thomas PQ, Brown A, Beddington RS: Hex: a homeobox gene revealing peri-implantation asymmetry in the mouse embryo and an early transient marker of endothelial cell precursors. Development. 1998, 125: 85-94.
35. Dong JZ, Dunstan DI: Expression of abundant mRNAs during somatic embryogenesis of white spruce [Picea glauca (Moench) Voss]. Planta. 1996, 199: 459-466. DOI: 10.1007/BF00195740
36. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science. 1994, 266: 1821-1828. DOI: 10.1126/science.7997877
37. Hunter T, Pines J: Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell. 1994, 79: 573-582. DOI: 10.1016/0092-8674(94)90543-6
38. Wang XH, Whyzmuzis CA, An S, Chen Y, Wu JM, Schneidau TA, Mallouh C, Tazaki H: Regulation of cell growth and the c-myc proto-oncogene expression by phorbol ester 12-0-tetradecanoyl phorbol-13-acetate (TPA) in the androgen-independent human prostatic JCA-1 cells. Biochem Mol Biol Int. 1994, 34: 47-53.
39. Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9: 1149-1163. DOI: 10.1101/gad.9.10.1149
40. Hall M, Peters G: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res. 1996, 68: 67-108. DOI: 10.1016/S0065-230X(08)60352-8
41. deToledo SM, Murphy LJ, Hatton TH, Friesen HG: Regulation of 70-kilodalton heat-shock-like messenger ribonucleic acid in vitro and in vivo by prolactin. Mol Endocrinol. 1987, 1: 430-434. DOI: 10.1210/mend-1-6-430
42. Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T: A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 1988, 53: 37-43. DOI: 10.1016/0092-8674(88)90485-0
43. Christy B, Nathans D: Functional serum response elements upstream of the growth factor-inducible gene zif268. Mol Cell Biol. 1989, 9: 4889-4895. DOI: 10.1128/MCB.9.11.4889
44. Cao XM, Koski RA, Gashler A, McKiernan M, Morris CF, Gaffney R, Hay RV, Sukhatme VP: Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol Cell Biol. 1990, 10: 1931-1939. DOI: 10.1128/MCB.10.5.1931
45. Darland T, Samuels M, Edwards SA, Sukhatme VP, Adamson ED: Regulation of Egr-1 (Zfp-6) and c-fos expression in differentiating embryonal carcinoma cells. Oncogene. 1991, 6: 1367-1376.
46. Haber DA, Buckler AJ: WT1: a novel tumor suppressor gene inactivated in Wilms' tumor. New Biol. 1992, 4: 97-106.
47. Madden SL, Rauscher FJ: Positive and negative regulation of transcription and cell growth mediated by the EGR family of zinc-finger gene products. Ann N Y Acad Sci. 1993, 684: 75-84. DOI: 10.1111/j.1749-6632.1993.tb32272.x
48. Yamashita H, Xu J, Erwin RA, Larner AC, Rui H: A lymphoma growth inhibitor blocks some but not all prolactin-stimulated signaling pathways. J Biol Chem. 1999, 274: 14699-14705. 10.1074/jbc.274.21.14699. DOI: 10.1074/jbc.274.21.14699
49. Wang Z, Gluck S, Zhang L, Moran MF: Requirement for phospholipase C-gamma1 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol. 1998, 18: 590-597. DOI: 10.1128/MCB.18.1.590
50. Smith MR, Court DW, Kim HK, Park JB, Rhee SG, Rhim JS, Kung HF: Overexpression of phosphoinositide-specific phospholipase Cgamma in NIH 3T3 cells promotes transformation and tumorigenicity. Carcinogenesis. 1998, 19: 177-185. 10.1093/carcin/19.1.177. DOI: 10.1093/carcin/19.1.177
51. Serve H, Yee NS, Stella G, Sepp-Lorenzino L, Tan JC, Besmer P: Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 1995, 14: 473-483.
52. Takuwa N, Fukui Y, Takuwa Y: Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol. 1999, 19: 1346-1358. DOI: 10.1128/MCB.19.2.1346
53. Yamashiro S, Okada M, Haraguchi M, Furukawa K, Lloyd KO, Shiku H: Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj J. 1995, 12: 894-900. DOI: 10.1007/BF00731251
54. Kume A, Nishiura H, Suda J, Suda T: Focal adhesion kinase upregulated by granulocyte-macrophage colony-stimulating factor but not by interleukin-3 in differentiating myeloid cells. Blood. 1997, 89: 3434-3442.
55. Tremblay L, Hauck W, Aprikian AG, Begin LR, Chapdelaine A, Chevalier S: Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma. Int J Cancer. 1996, 68: 164-171. 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W. DOI: 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W
56. Zachary I, Rozengurt E: Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell. 1992, 71: 891-894. DOI: 10.1016/0092-8674(92)90385-P
57. Ushikubi F, Aiba Y, Nakamura K, Namba T, Hirata M, Mazda O, Katsura Y, Narumiya S: Thromboxane A2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med. 1993, 178: 1825-1830. DOI: 10.1084/jem.178.5.1825
58. Liu C, Calogero A, Ragona G, Adamson E, Mercola D: EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity. Crit Rev Oncog. 1996, 7: 101-125. DOI: 10.1615/CritRevOncog.v7.i1-2.70
59. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED: Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res. 1995, 55: 5054-5062.
60. Liu C, Yao J, de Belle I, Huang RP, Adamson E, Mercola D: The transcription factor EGR-1 suppresses transformation of human fibrosarcoma HT1080 cells by coordinated induction of transforming growth factor-beta1, fibronectin, and plasminogen activator inhibitor-1. J Biol Chem. 1999, 274: 4400-4411. 10.1074/jbc.274.7.4400. DOI: 10.1074/jbc.274.7.4400
61. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED: Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer. 1997, 72: 102-109. 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L. DOI: 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L
62. Liu C, Adamson E, Mercola D: Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc Natl Acad Sci USA. 1996, 93: 11831-11836. 10.1073/pnas.93.21.11831. DOI: 10.1073/pnas.93.21.11831
63. Liu C, Rangnekar VM, Adamson E, Mercola D: Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther. 1998, 5: 3-28. 10.1016/S0928-4680(98)80286-1.
64. Rayhel EJ, Prentice DA, Tabor PS, Flurkey WH, Geib RW, Laherty RF, Schnitzer SB, Chen R, Hughes JP: Inhibition of Nb2 T-lymphoma cell growth by transforming growth factor-beta. Biochem J. 1988, 253: 295-298. DOI: 10.1042/bj2530295
65. Sukhatme VP: The Egr transcription factor family: from signal transduction to kidney differentiation. Kidney Int. 1992, 41: 550-553. DOI: 10.1038/ki.1992.79
66. Vara PM, Shore SK, Dhanasekaran N: Activated mutant of G alpha 13 induces Egr-1, c-fos, and transformation in NIH 3T3 cells. Oncogene. 1994, 9: 2425-2429.
67. Molnar G, Crozat A, Pardee AB: The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol Cell Biol. 1994, 14: 5242-5248. DOI: 10.1128/MCB.14.8.5242
68. de Belle I, Huang RP, Fan Y, Liu C, Mercola D, Adamson ED: p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis. Oncogene. 1999, 18: 3633-3642. 10.1038/sj/onc/1202696. DOI: 10.1038/sj.onc.1202696
69. Levine AJ, Momand J, Finlay CA: The p53 tumour suppressor gene. Nature. 1991, 351: 453-456. 10.1038/351453a0. DOI: 10.1038/351453a0
70. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol. 1999, 19: 1-11. DOI: 10.1128/MCB.19.1.1
71. Laroia G, Cuesta R, Brewer G, Schneider RJ: Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. Science. 1999, 284: 499-502. 10.1126/science.284.5413.499. DOI: 10.1126/science.284.5413.499
72. Winkles JA: Serum- and polypeptide growth factor-inducible gene expression in mouse fibroblasts. Prog Nucleic Acid Res Mol Biol. 1998, 58: 41-78. DOI: 10.1016/S0079-6603(08)60033-1
73. Cell Cycle Regulated Transcripts with Known Mammalian Homologs. [http://genomics.stanford.edu/yeast_cell_cycle/mammalian_homologs.html]
74. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987, 162: 156-159. 10.1006/abio.1987.9999. DOI: 10.1016/0003-2697(87)90021-2
75. Martin-Laurent F, Franken P, Gianinazzi S: Screening of cDNA fragments generated by differential RNA display. Anal Biochem. 1995, 228: 182-184. 10.1006/abio.1995.1337. DOI: 10.1006/abio.1995.1337
76. Pietu G, Alibert O, Guichard V, Lamy B, Bois F, Leroy E, Mariage-Sampson R, Houlgatte R, Soularue P, Auffray C: Novel gene transcripts preferentially expressed in human muscles revealed by quantitative hybridization of a high density cDNA array. Genome Res. 1996, 6: 492-503. DOI: 10.1101/gr.6.6.492
77. National Center for Biotechnology Information. [http://www.ncbi.nlm.nih.gov]
78. Hosokawa Y, Yang M, Kaneko S, Tanaka M, Nakashima K: Synergistic gene expressions of cyclin E, cdk2, cdk5 and E2F-1 during the prolactin-induced G1/S transition in rat Nb2 pre-T lymphoma cells. Biochem Mol Biol Int. 1995, 37: 393-399.
79. Too CK: Differential expression of elongation factor-2, alpha4 phosphoprotein and Cdc5-like protein in prolactin-dependent/independent rat lymphoid cells. Mol Cell Endocrinol. 1997, 131: 221-232. 10.1016/S0303-7207(97)00112-3. DOI: 10.1016/S0303-7207(97)00112-3
80. Richards JF: Ornithine decarboxylase activity in tissues of prolactin-treated rats. Biochem Biophys Res Commun. 1975, 63: 292-299. DOI: 10.1016/S0006-291X(75)80042-8
81. Axtell SM, Truong TM, O'Neal KD, Yu-Lee LY: Characterization of a prolactin-inducible gene, clone 15, in T cells. Mol Endocrinol. 1995, 9: 312-318.
82. Too CK, Knee R, Pinette AL, Li AW, Murphy PR: Prolactin induces expression of FGF-2 and a novel FGF-responsive NonO/p54nrb-related mRNA in rat lymphoma cells. Mol Cell Endocrinol. 1998, 137: 187-195. 10.1016/S0303-7207(97)00240-2. DOI: 10.1016/S0303-7207(97)00240-2
83. Wilson TM, Yu-Lee LY, Kelley MR: Coordinate gene expression of luteinizing hormone-releasing hormone (LHRH) and the LHRH-receptor after prolactin stimulation in the rat Nb2 T-cell line: implications for a role in immunomodulation and cell cycle gene expression. Mol Endocrinol. 1995, 9: 44-53.
84. Puissant C, Mitev V, Lemnaouar M, Manceau V, Sobel A, Houdebine LM: Stathmin gene expression in mammary gland and in Nb2 cells. Biol Cell. 1995, 85: 109-115. 10.1016/0248-4900(96)85271-3. DOI: 10.1016/0248-4900(96)85271-3